Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-106
Closed -$4K 1028
2022
Q3
$4K Sell
106
-148
-58% -$5.87K ﹤0.01% 941
2022
Q2
$9K Buy
254
+148
+140% +$6.12K ﹤0.01% 791
2022
Q1
$5K Hold
106
﹤0.01% 920
2021
Q4
$5K Hold
106
﹤0.01% 910
2021
Q3
$4K Hold
106
﹤0.01% 910
2021
Q2
$5K Sell
106
-73
-41% -$3.43K ﹤0.01% 898
2021
Q1
$8K Buy
179
+73
+69% +$3.06K ﹤0.01% 738
2020
Q4
$3K Hold
106
﹤0.01% 841
2020
Q3
$2K Hold
106
﹤0.01% 867
2020
Q2
$2K Hold
106
﹤0.01% 898
2020
Q1
$1.9K Hold
106
﹤0.01% 810
2019
Q4
$4.19K Hold
106
﹤0.01% 952
2019
Q3
$3.82K Buy
+106
New +$3.8K ﹤0.01% 1066

Other funds holding SNV

Evoke Wealth's SNV Position: Q4 2022 in Review

Evoke Wealth sold out of Synovus (SNV) in Q4 2022, closing a stake of 106 shares — an estimated $4K sold.

Evoke Wealth first reported a position in SNV in Q3 2019 and held it in 13 quarters. The position peaked at $9K in Q2 2022. 419 funds tracked by Wall St. Rank hold SNV as of Q4 2022.

  • Evoke Wealth reported no remaining Synovus position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 106 Synovus shares in Q4 2022, an estimated $4K.
  • Evoke Wealth first reported a position in Synovus in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Synovus position peaked at $9K in Q2 2022.
  • 419 funds tracked by Wall St. Rank held Synovus as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.